India Pharma Outlook Team | Monday, 15 September 2025
Fermenta Biotech Limited, the top producer of high-quality APIs, intermediates, and nutritional premixes for international markets in India, declared that its discovery of a plant-based vitamin D3 has been officially given a patent by the Indian Patent Office.
A major step forward in its innovation pipeline, Fermenta's recently awarded patent protects its exclusive method of making plant-based vitamin D3, further solidifying its position as a leader in the global vitamin D3 market.
This industry-leading vegan product puts Fermenta at the vanguard of the plant-based nutrition revolution and addresses the growing need for sustainably sourced, ethically obtained food worldwide.
Also Read: Sun Pharma & Lupin to develop affordable anti-obesity pills
The invention capitalizes on new prospects in the nutraceutical and food fortification sectors, where sustainable, plant-derived ingredients fetch premiums and expanding market share, by making it possible to produce Vitamin D3 that is totally vegan and vegetarian-friendly.
Prashant Nagre, Managing Director of Fermenta, said: "The grant of this patent portfolio is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions.
Plant-based Vitamin D3 represents the future of nutrition supplements , and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India's role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness."
